1. Home
  2. TPCS vs OKUR Comparison

TPCS vs OKUR Comparison

Compare TPCS & OKUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPCS
  • OKUR
  • Stock Information
  • Founded
  • TPCS 1956
  • OKUR 2011
  • Country
  • TPCS United States
  • OKUR United States
  • Employees
  • TPCS N/A
  • OKUR N/A
  • Industry
  • TPCS Metal Fabrications
  • OKUR
  • Sector
  • TPCS Industrials
  • OKUR
  • Exchange
  • TPCS Nasdaq
  • OKUR NYSE
  • Market Cap
  • TPCS 42.6M
  • OKUR 34.9M
  • IPO Year
  • TPCS N/A
  • OKUR N/A
  • Fundamental
  • Price
  • TPCS $3.49
  • OKUR $2.35
  • Analyst Decision
  • TPCS
  • OKUR Strong Buy
  • Analyst Count
  • TPCS 0
  • OKUR 4
  • Target Price
  • TPCS N/A
  • OKUR $32.25
  • AVG Volume (30 Days)
  • TPCS 29.2K
  • OKUR 118.8K
  • Earning Date
  • TPCS 04-08-2025
  • OKUR 08-14-2025
  • Dividend Yield
  • TPCS N/A
  • OKUR N/A
  • EPS Growth
  • TPCS N/A
  • OKUR N/A
  • EPS
  • TPCS N/A
  • OKUR N/A
  • Revenue
  • TPCS $33,154,058.00
  • OKUR N/A
  • Revenue This Year
  • TPCS N/A
  • OKUR N/A
  • Revenue Next Year
  • TPCS N/A
  • OKUR N/A
  • P/E Ratio
  • TPCS N/A
  • OKUR N/A
  • Revenue Growth
  • TPCS 8.71
  • OKUR N/A
  • 52 Week Low
  • TPCS $2.05
  • OKUR $1.70
  • 52 Week High
  • TPCS $4.42
  • OKUR $20.00
  • Technical
  • Relative Strength Index (RSI)
  • TPCS 45.47
  • OKUR N/A
  • Support Level
  • TPCS $3.21
  • OKUR N/A
  • Resistance Level
  • TPCS $3.43
  • OKUR N/A
  • Average True Range (ATR)
  • TPCS 0.21
  • OKUR 0.00
  • MACD
  • TPCS -0.08
  • OKUR 0.00
  • Stochastic Oscillator
  • TPCS 24.63
  • OKUR 0.00

About TPCS TechPrecision Corporation Common stock

Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components.

About OKUR ONKURE THERAPEUTICS INC

OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.

Share on Social Networks: